Silencing STAT3 enhances sensitivity of cancer cells to doxorubicin and inhibits tumor progression
Silencing STAT3 enhances sensitivity of cancer cells to doxorubicin and inhibits tumor progression
نویسندگان: فرناز حاجی زاده , وحید کارپیشه , عطا محمودپور , صنم دولتی , مهدی یوسفی , فرهاد جدیدی نیارق
کلمات کلیدی: Cancer, Nanoparticle, STAT3, siRNA, Doxorubicin
نشریه: 22959 , 1 , 275 , 2021
| نویسنده ثبت کننده مقاله |
فرهاد جدیدی نیارق |
| مرحله جاری مقاله |
تایید نهایی |
| دانشکده/مرکز مربوطه |
مرکز تحقیقات ایمونولوژی |
| کد مقاله |
75601 |
| عنوان فارسی مقاله |
Silencing STAT3 enhances sensitivity of cancer cells to doxorubicin and inhibits tumor progression |
| عنوان لاتین مقاله |
Silencing STAT3 enhances sensitivity of cancer cells to doxorubicin and inhibits tumor progression |
| ناشر |
14 |
| آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ |
بلی |
| عنوان نشریه (خارج از لیست فوق) |
|
| نوع مقاله |
Original Article |
| نحوه ایندکس شدن مقاله |
ایندکس شده سطح یک – ISI - Web of Science |
| آدرس لینک مقاله/ همایش در شبکه اینترنت |
|
| Aims: Despite extensive efforts to find new treatments, chemotherapy is still one of the first and foremost choices for cancer treatment. The main problems of using these drugs are the resistance of cancer cells and reducing their sensitivity to chemotherapy as well as the side effects of their systemic administration. Because STAT3 plays a very important role in the survival and susceptibility of cancer cells to apoptosis, we hypothesized that sup-pression of STAT3 expression could induce greater susceptibility to DOX-induced cancer cell death. Materials and methods: We used pegylated chitosan lactate nanoparticles (NPs) functionalized by TAT peptide and folate to deliver STAT3 siRNA and DOX to cancer cells simultaneously, both in vitro and in vivo. Key findings: The results showed that NPs could effectively deliver siRNA and DOX to cancer cells, which was associated with suppression of STAT3 expression and increased induction of DOX-mediated cell death. Concomitant delivery of DOX and STAT3 siRNA also suppressed tumor growth in 4T1 and CT26 cancer models, which was associated with induction of anti-tumor immune responses. Significance: These findings suggest that the use of NPs can be an effective strategy for the targeted delivery of STAT3-specific siRNA/DOX to cancer cells |
| نام فایل |
تاریخ درج فایل |
اندازه فایل |
دانلود |
| Silencing STAT3 enhances sensitivity of cancer cells to doxorubicin and inhibits tumor progression.pdf | 1400/02/04 | 4552342 | دانلود |